73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me
Could a dramatic rise in liver cancer in Australia be linked to climate change?

Could a dramatic rise in liver cancer in Australia be linked to climate change?

byQueensland University of TechnologyCredit:Science of The Total Environment(2022). DOI: 10.1016/j.scitotenv.2022.160412Professor Wenbiao Hu from the QUT School of Public Health and

Could a dramatic rise in liver cancer in Australia be linked to climate change?

byQueensland University of TechnologyCredit:Science of The Total Environment(2022). DOI: 10.1016/j.scitotenv.2022.160412Professor Wenbiao Hu from the QUT School of Public Health and
Estrogen Receptor Mutation Prospects in Endometrial Cancer Treatment

Estrogen Receptor Mutation Prospects in Endometrial Cancer Treatment

byHemalatha Manikandanon August 22, 2023Inhibiting CDK9, a protein that works withestrogen receptors, was effective at minimizing the proliferation ofendometrial cancerce

Estrogen Receptor Mutation Prospects in Endometrial Cancer Treatment

byHemalatha Manikandanon August 22, 2023Inhibiting CDK9, a protein that works withestrogen receptors, was effective at minimizing the proliferation ofendometrial cancerce
B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells
Noninvasive Test Shows Promise in Early Bladder Cancer Diagnosis

Noninvasive Test Shows Promise in Early Bladder Cancer Diagnosis

byColleen Fleisson August 15, 2023A new molecular diagnostic method that identifies primary bladder cancer in patients who observe blood in their urine (hematuria) could expediteblad

Noninvasive Test Shows Promise in Early Bladder Cancer Diagnosis

byColleen Fleisson August 15, 2023A new molecular diagnostic method that identifies primary bladder cancer in patients who observe blood in their urine (hematuria) could expediteblad
Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative

Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers

by Will Cushman,University of Wisconsin-MadisonThis image shows the effect of pro-inflammatory cytokines on the growth of a mouse intestinal organoid. Intestinal stem cells (red) are indicative
Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in
Study of intravenous mistletoe extract to treat advanced cancer

Study of intravenous mistletoe extract to treat advanced cancer

byJohns Hopkins University School of MedicineIn Texas, the type of mistletoe you’ll find on trees typically has white berries in clusters. Credit: Pixabay/CC0 Public DomainMistletoe extract has

Study of intravenous mistletoe extract to treat advanced cancer

byJohns Hopkins University School of MedicineIn Texas, the type of mistletoe you’ll find on trees typically has white berries in clusters. Credit: Pixabay/CC0 Public DomainMistletoe extract has
Analysis reveals adverse effects of complex cancer therapies called antibody drug conjugates

Analysis reveals adverse effects of complex cancer therapies called antibody drug conjugates

byWileyCredit: Unsplash/CC0 Public DomainOver the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for

Analysis reveals adverse effects of complex cancer therapies called antibody drug conjugates

byWileyCredit: Unsplash/CC0 Public DomainOver the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for
Study shows older age and smoking most important risk factors for developing any cancer

Study shows older age and smoking most important risk factors for developing any cancer

byAmerican Cancer SocietyCredit: Unsplash/CC0 Public DomainA new large study led by researchers at the American Cancer Society (ACS) shows older age and smoking are the two most important risk f

Study shows older age and smoking most important risk factors for developing any cancer

byAmerican Cancer SocietyCredit: Unsplash/CC0 Public DomainA new large study led by researchers at the American Cancer Society (ACS) shows older age and smoking are the two most important risk f
Results mixed for twice-daily APBI in early breast cancer

Results mixed for twice-daily APBI in early breast cancer

(HealthDay)—Accelerated partial breast irradiation (APBI) delivered twice per day over one week to the tumor bed is noninferior to whole breast irradiation for preventing ipsilateral breast tumor recu

Results mixed for twice-daily APBI in early breast cancer

(HealthDay)—Accelerated partial breast irradiation (APBI) delivered twice per day over one week to the tumor bed is noninferior to whole breast irradiation for preventing ipsilateral breast tumor recu